Enhanced Systems and Methods for Treating Inflammatory Bowel Disease through Peripheral Nerve Stimulation

The inventive concept enhances the original peripheral nerve stimulation system for treating inflammatory bowel disease by introducing tailored electrical nerve stimulation signals, real-time monitoring, and personalized therapy, leading to improved treatment outcomes and enhanced patient safety.

The original patent disclosed a method for treating inflammatory bowel disease through peripheral nerve stimulation, but it had limitations in terms of signal customization, real-time feedback, and patient-specific optimization. The new inventive concept addresses these limitations by incorporating advanced signal processing, monitoring capabilities, and personalized therapy, thereby improving treatment efficacy and reducing potential side effects.

The inventive concept comprises a stimulation device configured to deliver tailored electrical nerve stimulation signals to specific peripheral nerves, modulating both parasympathetic and sympathetic nervous systems to activate an anti-inflammatory pathway. The system includes real-time monitoring capabilities to adjust the electrical stimulation parameter based on the patient's inflammatory response. Additionally, the system can be personalized by determining a patient's specific nerve conduction velocity and adjusting the electrical stimulation parameter accordingly. The inventive concept also encompasses simultaneous stimulation of multiple peripheral nerves to enhance the anti-inflammatory effect.

The new claims introduce novel elements such as tailored electrical nerve stimulation signals, real-time monitoring, and personalized therapy, which are not present in the original patent. These advancements provide a non-obvious improvement over the prior art, enabling more effective and safe treatment of inflammatory bowel disease.

Alternative embodiments of the inventive concept could include varying the signal frequency, pulse width, or amplitude to optimize the anti-inflammatory effect. Additionally, the system could be adapted for use with other inflammatory diseases or conditions, such as rheumatoid arthritis or autoimmune hepatitis.

The enhanced peripheral nerve stimulation system has significant commercial potential in the treatment of inflammatory bowel disease, with a growing market demand for non-pharmacological and minimally invasive therapies. The system could be marketed to gastroenterologists, pain management specialists, and other healthcare professionals, with potential applications in hospitals, clinics, and private practices.